Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy

Gregg W Stone1, Herbert D Aronow

  • 1Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 10022, USA. gstone@crf.org

Insights

Dual antiplatelet therapy, including aspirin and clopidogrel, is crucial for preventing complications after percutaneous coronary intervention (PCI). This regimen effectively reduces stent thrombosis and future atherothrombotic events when used long-term.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Pharmacology

Background:

  • Percutaneous coronary intervention (PCI) can cause arterial wall injury, leading to platelet activation and thrombosis.
  • Platelet hyperreactivity is a known factor in atherothrombosis and a complication of PCI, including acute/subacute thrombosis and restenosis.

Purpose of the Study:

  • To evaluate the efficacy of antithrombotic and anticoagulant therapies in minimizing thrombotic complications post-PCI.
  • To determine optimal dual antiplatelet therapy (DAPT) duration for preventing stent thrombosis.
  • To outline comprehensive long-term care strategies for patients undergoing PCI.

Main Methods:

  • Comparison of aspirin plus thienopyridine therapy versus aspirin plus heparin and warfarin.
  • Assessment of DAPT (aspirin and clopidogrel) duration for bare-metal and drug-eluting stents.
  • Review of systemic pharmacotherapy and lifestyle modifications for managing coronary atherothrombosis.

Main Results:

  • Aspirin plus a thienopyridine is more effective than aspirin/heparin/warfarin in preventing ischemic events and bleeding.
  • DAPT with aspirin and clopidogrel is recommended for at least 4 weeks (bare-metal stents) to 3-6 months (drug-eluting stents).
  • Long-term DAPT (aspirin plus clopidogrel) for at least 12 months is advised for prophylaxis against future atherothrombotic events.

Conclusions:

  • Dual antiplatelet therapy with aspirin and clopidogrel is the preferred regimen for minimizing thrombotic complications after PCI.
  • Comprehensive management including pharmacotherapy and lifestyle changes is essential for long-term atherothrombosis risk reduction.
  • Extended DAPT duration is critical for preventing both early and late stent thrombosis and subsequent atherothrombotic events.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...